Former Glaxo Executive To Lead Trump’s Vaccine Team

Politico reports:

The former head of GlaxoSmithKline’s vaccine division will serve as the Trump administration’s “therapeutics czar,” working to speed the development of potential coronavirus vaccines, three individuals with knowledge of the selection told POLITICO.

Moncef Slaoui, who left the drugmaker in 2017 and has worked as a venture capitalist, will help coordinate the development of Covid-19 vaccines and treatments in a role shared between the Health and Human Services and Defense departments.

President Donald Trump has instructed officials to attempt to rush a vaccine to market this year, part of an effort the administration is calling “Operation Warp Speed.”